Biogen (BIIB) PT Raised to $350 at Canaccord Genuity Ahead of 4Q17 Earnings Announcement on 1/25 BMO; 'Lower Tax Rate in 2018+ Main Driver'
Tweet Send to a Friend
Canaccord Genuity raised its price target on Biogen (NASDAQ: BIIB) to $350.00 (from $340.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
